The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bobrova L.A.

Sechenov First Moscow State Medical University (Sechenov University)

Bobkova I.N.

Sechenov First Moscow State Medical University (Sechenov University)

There is a nuance

Authors:

Bobrova L.A., Bobkova I.N.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2023;(12): 64‑68

Read: 567 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Bobrova LA, Bobkova IN. There is a nuance. Non Nocere. New Therapeutic Journal. 2023;(12):64‑68. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Diagnosis of kidney damage in antiphospholipid syndrome.

Authors:

Bobrova L.A.

Sechenov First Moscow State Medical University (Sechenov University)

Bobkova I.N.

Sechenov First Moscow State Medical University (Sechenov University)

Close metadata

References:

  1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.  https://doi.org/10.1111/j.1538-7836.2006.01753.x.
  2. Reshetnyak T.M. Antiphospholipid syndrome: diagnosis and clinical manifestations (a lecture). Rheumatology Science and Practice. 2014;52(1):56-71. (In Russ.) https://doi.org/10.14412/1995-4484-2014-56-71
  3. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752-763.  https://doi.org/10.1056/NEJMra002974
  4. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019-1027. https://doi.org/10.1002/art.10187
  5. Cervera R, Espinosa G, Bucciarelli S, Gómez-Puerta JA, Font J. Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry. Autoimmun Rev. 2006;6(2):81-84.  https://doi.org/10.1016/j.autrev.2006.06.009
  6. Caraiola S, Voicu L, Baicus A, Baicus C. Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss. J Pers Med. 2023;13(11):1549. Published 2023 Oct 29.  https://doi.org/10.3390/jpm13111549
  7. Gérardin C, Bihan K, Salem JE, et al. Drug-induced antiphospholipid syndrome: Analysis of the WHO international database. Autoimmun Rev. 2022;21(5):103060. https://doi.org/10.1016/j.autrev.2022.103060
  8. Korotchaeva Y.V., Kozlovskaya N.L. Nephropathy associated with antiphospholipid syndrome. In the book: Nephrology. Clinical recommendations / edited by E.M. Shilov, A.V. Smirnov, N.L. Kozlovskaya. Moscow: GEOTAR-Media, 2016. - P. 376-388. 
  9. El Hasbani G, Saliba AN, Uthman I, Taher AT. Hematological manifestations of antiphospholipid syndrome: Going beyond thrombosis. Blood Rev. 2023;58:101015. https://doi.org/10.1016/j.blre.2022.101015
  10. Tayem MG, Shahin L, Shook J, Kesselman MM. A Review of Cardiac Manifestations in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome With Focus on Endocarditis. Cureus. 2022;14(1): e21698. Published 2022 Jan 28.  https://doi.org/10.7759/cureus.21698
  11. Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;82(10):1258-1270. https://doi.org/10.1136/ard-2023-224609
  12. Canaud G, Bienaimé F, Tabarin F, et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 2014;371(4):303-312.  https://doi.org/10.1056/NEJMoa1312890
  13. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol. 1986;13(3):486-489. 
  14. Domingues V, Chock EY, Dufrost V, et al. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmun Rev. 2022;21(10):103158. https://doi.org/10.1016/j.autrev.2022.103158
  15. Kozlovskaya N.L. Vascular lesion of kidneys in antiphospholipid syndrome (Literature review). Nephrology and dialysis. 20068(3):206-219. 
  16. Namazi MH, Khaheshi I, Serati AR, Movahed MR. Resistant hypertension due to unilateral renal artery occlusion as the first presentation of antiphospholipid syndrome. Cardiovasc Revasc Med. 2015;16(3):190-191.  https://doi.org/10.1016/j.carrev.2014.09.004
  17. Eren N, Gungor O, Kocyigit I, et al. Acute renal infarction in Turkey: a review of 121 cases. Int Urol Nephrol. 2018;50(11):2067-2072. https://doi.org/10.1007/s11255-018-1979-6
  18. O’Neill WC, Bardelli M, Yevzlin AS. Imaging for renovascular disease. Semin Nephrol. 2011;31(3):272-282.  https://doi.org/10.1016/j.semnephrol.2011.05.007
  19. Sangle SR, D’Cruz DP, Jan W, et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis. 2003;62(10):999-1002. https://doi.org/10.1136/ard.62.10.999
  20. Conti F, Ceccarelli F, Gigante A, et al. Ultrasonographic Evaluation of Resistive Index and Renal Artery Stenosis in Patients with Anti-Phospholipid Syndrome: Two Distinct Mechanisms? Ultrasound Med Biol. 2015;41(7):1814-1820. https://doi.org/10.1016/j.ultrasmedbio.2015.02.009
  21. Sangle SR, D’Cruz DP, Abbs IC, Khamashta MA, Hughes GR. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford). 2005 Mar;44(3):372-377.  https://doi.org/10.1093/rheumatology/keh490
  22. Kozlovskaya N.L., Bobrova L.A., Kirsanova T.V., Shakhnova E.A., Meteleva N.A. Thrombosis/stenosis of renal arteries as a manifestation of antiphospholipid syndrome (APS). Collection of theses of the All-Russian conference with international participation “Thrombosis, bleeding, DIC-syndrome: modern approaches to diagnostics and treatment”. Appendix No. 7. M., 2009. – P. 51-52. 
  23. Meteleva N.A. Kidney damage in primary antiphospholipid syndrome: specialty 14.00.48: dissertation abstract for the degree of candidate of medical sciences. – Moscow, 2004.
  24. Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology (Carlton). 2007;12(5):474-480.  https://doi.org/10.1111/j.1440-1797.2007.00792.x
  25. Erre GL, Bosincu L, Faedda R, et al. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. Rheumatol Int. 2014;34(4):535-541.  https://doi.org/10.1007/s00296-013-2900-3
  26. Demyanova K.A., Kozlovskaya N.L., Bobrova L.A., Kuchieva A.M. Poliorgan failure in acute thrombotic microangiopathies. Nephrology and Dialysis. 2013;15(4):368. 
  27. Rodríguez-Pintó I, Moitinho M, Santacreu I, et al. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016;15(12):1120-1124. https://doi.org/10.1016/j.autrev.2016.09.010
  28. Kozlovskaya N.L. Antiphospholipid syndrome: difficulties of diagnostics. Physician. 2006;10:10-12. 
  29. Abreu MM, Danowski A, Wahl DG, et al. The relevance of «non-criteria» clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. Autoimmun Rev. 2015;14(5):401-414.  https://doi.org/10.1016/j.autrev.2015.01.002
  30. Tektonidou MG, Sotsiou F, Moutsopoulos HM. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol. 2008;35(10):1983-1988.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.